Hennion & Walsh Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-35,740
| Closed | -$1.85M | – | 822 |
|
|
2022
Q3 | $1.85M | Sell |
35,740
-1,198
| -3% | -$61.9K | 0.12% | 204 |
|
|
2022
Q2 | $915K | Sell |
36,938
-30,852
| -46% | -$764K | 0.06% | 333 |
|
|
2022
Q1 | $1.7M | Buy |
67,790
+11,447
| +20% | +$287K | 0.09% | 246 |
|
|
2021
Q4 | $2.05M | Buy |
56,343
+17,908
| +47% | +$652K | 0.1% | 228 |
|
|
2021
Q3 | $657K | Sell |
38,435
-1,903
| -5% | -$32.5K | 0.03% | 450 |
|
|
2021
Q2 | $540K | Buy |
40,338
+1,510
| +4% | +$20.2K | 0.03% | 508 |
|
|
2021
Q1 | $1.99M | Buy |
+38,828
| New | +$1.99M | 0.12% | 231 |
|